Curis, Inc. (CRIS) Social Stream
CURIS INC (CRIS) Price Targets From Analysts
Use the tables below to see what analysts covering CURIS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 22 months, CRIS's average price target has gone down $9.75.
Over the past 38 weeks, CRIS's average upside potential has been 1,014.98%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CRIS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 43 weeks, CRIS's average broker recommendation rating worsened by 0.42.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, CURIS INC's upside potential (average analyst target price relative to current price) is greater than 1179.84% of them.
- To contextualize these metrics, consider that out of all US stocks, CURIS INC's number of analysts covering the stock is greater than 139.91% of them.
- CURIS INC's variance in analysts' estimates is lower than -604.76% of stocks in the small market cap category.
- In terms of how CURIS INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 283.74% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CURIS INC are AGEN, PTE, and ACOR.
View All Top Stocks by Price Target
Is CRIS a Buy, Hold or Sell? See the POWR Ratings now!